Drug Designing

Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three dimensional structure and computational techniques are known as structure based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogs.

  • Structure Based Drug Design
  • Ligand Based Drug Design
  • Drug Interactions
  • Virtural Screening and Drug Design
  • Computation Biology for Drug Target Identification and Validation
  • Nanomedicine

Related Conference of Drug Designing

September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 11-12, 2018

13th International Conference on Metabolomics and Systems Biology

Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
July 31-August 01, 2019

6th International Conference on Glycobiology & Glycoproteomics

Chicago, Illinois, USA
September 23-24, 2019

8th Glycobiology World Congress

Barcelona, Spain

Drug Designing Conference Speakers

Recommended Sessions

Related Journals

Are you interested in